← Advanced Bronchoscopy

Endobronchial Valves for Persistent Air Leaks in Necrotizing Pneumonia and Complex Pleuropulmonary Infections: A National Analysis of Safety and Efficacy

IPBronch Review

🎯 Background & Rationale

  • Clinical dogma: Active pulmonary infection is traditionally considered an absolute contraindication to endobronchial valve (EBV) placement due to fears of trapping secretions and worsening sepsis.
  • Persistent air leaks: Management of alveolar-pleural fistulas exceeding 5 days remains a major thoracic morbidity, often leaving frail patients with limited options.
  • Evidence gap: Large-scale data comparing EBV outcomes in infected versus non-infectious air leaks have been lacking, prompting this national analysis.

👥 Study Design & Population

  • Study type: Retrospective national cohort study utilizing the National Inpatient Sample database from 2016 to 2023.
  • Population: Weighted total of 1,760 adult hospitalizations undergoing bronchoscopic EBV placement for persistent air leaks or pneumothorax.
  • Cohorts: Stratified into non-infectious air leaks (52.6%) and complex pleuropulmonary infections including necrotizing pneumonia, lung abscess, or empyema (47.4%).

📈 Methodology & Rigor

  • Exclusion filters: Rigorously excluded elective admissions, same-day procedures on admission, and cases with missing or invalid procedural dates to ensure proper temporal sequencing.
  • Statistical approach: Utilized multivariable logistic regression to identify independent predictors of composite clinical failure while adjusting for disease severity, mechanical ventilation, and comorbidities.
  • Administrative limitations: Relied on ICD-10 coding, which resulted in a high rate of uncodable microbiological data (69.5%) and limited granular procedural details.

🔬 Key Findings [or Planned Endpoints]

  • Primary failure rate: Complex infection was not independently associated with composite clinical failure after multivariable adjustment (P = 0.994).
  • Mechanical ventilation: Positive pressure ventilation was independently associated with an increased odds of clinical failure (aOR 3.00, P < 0.001).
  • Pathogen-specific risk: Methicillin-resistant Staphylococcus aureus (MRSA) pneumonia was associated with approximately fourfold higher odds of composite clinical failure (aOR 3.90, P = 0.030).
  • Resource utilization: The infection cohort experienced significantly longer length of stay (24.9 vs 16.0 days, P < 0.001) and higher hospital costs ($93,817 vs $46,669, P < 0.001).
  • Device retrieval: Valve extraction rates were higher in the complex infection cohort compared to non-infectious controls (12.6% vs 5.4%).

⚖️ Critical Appraisal

  • Confounding factors: Patients with complex infections presented with significantly higher baseline severity of illness (71.3% APR-DRG extreme tier vs 25.9%), reflecting advanced disease complexity.
  • Coding granularity: Administrative datasets lack anatomical specificity to confirm whether EBVs were deployed directly into the infected lobe or whether leaks were remote from the infection.
  • Selection bias: Post-surgical infectious salvage cases demonstrated markedly worse unadjusted outcomes, representing a distinctly higher-risk phenotype that warrants careful patient selection.

💡 The Clinical Bottom Line

  • Reevaluating dogma: Active pleuropulmonary infection should not be viewed as an absolute contraindication to EBV placement when aggressive pleural drainage is established.
  • Patient selection: Interventional pulmonologists can cautiously offer EBVs as a bridge-to-healing in infected, non-surgical candidates, though mechanical ventilation and MRSA bacteriology signal significantly higher failure rates.
  • Practice takeaway: Ensure meticulous pleural source control before deployment, and anticipate a higher requirement for secondary device adjustments or extractions in infected fields.

Background Endobronchial valve (EBV) placement for persistent air leaks (PAL) in active pulmonary infection remains controversial due to foreign body concerns. We compared EBV outcomes in infected patients against non-infectious controls. Methods We analyzed the National Inpatient Sample (2016–2023) for adults undergoing EBV placement for air leaks. Cohorts were stratified into non-infectious air leaks and complex pleuropulmonary infections. The primary outcome was clinical failure defined as mortality, surgical intervention, or new chest tube placement. Results Of 1,760 weighted patients, 52.6% had non-infectious leaks and 47.4% complex infections. Complex infection patients had longer length of stay (24.9 vs 16.0 days, p < 0.001) and higher hospital costs ($93,817 vs $46,669, p < 0.001). In multivariate analysis, infection was not an independent predictor of failure (p = 0.994); however, mechanical ventilation (aOR 3.00; p < 0.001) was associated with clinical failure in the adjusted model, and MRSA pneumonia (aOR 3.90; p = 0.030) was associated with clinical failure in a separate pathogen-adjusted analysis. Conclusions Among EBV-treated hospitalizations, Complex Infection was not significantly associated with composite clinical failure after adjustment, though device extraction rates were notably higher in this cohort. Mechanical ventilation was associated with clinical failure in the main adjusted model, and MRSA was associated with clinical failure in a separate pathogen-adjusted analysis.
Read the full paper ↗

Keep reading

N opens the next one